Health insurance; prohibiting contract provisions; establishing violations; creating waiver; allowing subpoena; allowing administrative penalty; allowing denial of sale; prohibiting limitations of network. Effective date.
SB 1626 creates a new section of Oklahoma insurance law aimed at restricting certain contract terms in health care provider agreements. It defines and prohibits several provisions in health care contracts, including all-or-nothing clauses, anti-steering clauses, anti-tiering clauses, gag clauses, and most-favored-nations clauses, as well as any other clause the Insurance Commissioner determines has anticompetitive effects. The bill applies to contracts between health care providers and health insurance carriers, health plan administrators, or related contracting entities.
The bill also establishes a waiver process. A party to a health care contract containing one of the prohibited provisions may submit the contract to the Insurance Commissioner for review, and the Commissioner must approve or deny the waiver within 60 days. A waiver may be granted only if the Commissioner finds that the provision improves consumer welfare, that the benefit outweighs harm to competition, that the same result could not be achieved through less restrictive means, and that the arrangement is not otherwise an unlawful restraint of trade. Contracts containing prohibited provisions without a waiver are unenforceable.
SB 1626 would add new enforcement tools to Oklahoma’s insurance and consumer protection framework by making violations an unfair or deceptive act under Title 36 and by authorizing enforcement by the Attorney General. It also gives the Attorney General subpoena power, allows injunctive and other equitable relief, and permits civil and criminal penalties for certain violations. The Insurance Commissioner would gain inspection authority over carrier records, the ability to require lists of recent contracts and pricing agreements, authority to impose daily administrative penalties, and power to deny the sale of a health insurance plan that violates the new requirements. The bill expressly preserves network design and cost/quality initiatives, including tiered networks, accountable care organizations, and steering to centers of excellence, so long as those initiatives do not rely on the banned contract clauses.
The available legislative record shows no committee transcript, vote tally, or recorded floor debate, so there is no direct evidence of support or opposition from discussion. Based on the bill’s structure, the measure appears to be framed as a consumer-protection and competition bill, with a focus on limiting restrictive contracting practices in health insurance markets. Its inclusion of a waiver process and an express carveout for network design suggests an attempt to balance anti-competitive concerns with flexibility for insurers and providers.
The main points of contention are likely to be the scope of the prohibited clauses and the breadth of regulatory enforcement. Health insurers and plan administrators may object to limits on contract negotiation tools such as all-or-nothing, anti-steering, anti-tiering, gag, and most-favored-nations clauses, while providers and consumer advocates may support the restrictions as promoting transparency and competition. Another likely issue is the Commissioner’s discretion to identify additional anticompetitive clauses by regulation, along with the Attorney General’s subpoena and penalty authority. The waiver process may also be debated because it gives the Commissioner significant gatekeeping power over when otherwise prohibited terms may be allowed.